The shortened trading week due to the Fourth of July holiday on Friday started strong on Monday, with the S&P 500 closing at a record high, generating a 10.57% return in the second quarter.
One of the stocks benefiting from the index’s 0.52% gain yesterday was Royal Caribbean Cruises (RCL), one of the world’s largest cruise operators. RCL stock was up 1.2% on the day, jumping into Barchart’s Top 100 Stocks to Buy, in the 87th spot.
In the past year, Royal Caribbean’s stock has gained over 100%, hitting 52-week highs on 46 occasions. As I write this on Tuesday morning, RCL stock is trading above $316, poised to set an all-time high.
Times have changed significantly since hitting a 10-year low of $19.25 in March 2020, driven entirely by a global shutdown in travel due to the COVID-19 pandemic.
I’ve been a long-time bull when it comes to cruise stocks generally–and Royal Caribbean Cruises specifically. I like the way it operates its business. I don’t see cruising slowing down without an outside economic or health-related situation slowing it down.
That said, it has never traded higher, and while it has significant momentum—up 21% in the past month alone—its valuation is moving into nosebleed territory.
The FOMO (fear of missing out) on RCL is high. Should you bite and buy some of its stock?
Here are the pros and cons of doing so.
In one word: Valuation. It ain’t cheap.
Analysts expect it to earn $15.42 a share in 2025 and $17.66 in 2026. At its current share price of $316.99, it trades at 20.6 times its forward 2025 EPS and 17.9 times its forward 2026 EPS.
The bullish argument you can make is that this multiple isn’t excessive compared to the S&P 500, which currently trades at 21.9x its 2026 forward earnings.
Before the pandemic, RCL stock had never traded above $150, with a forward EPS multiple no higher than 15.36x (as of the end of 2017), according to S&P Global Market Intelligence.
How do analysts feel about RCL stock? Of the 24 covering RCL, 19 rate it a Buy (4.54 out of 5), so it’s highly regarded by Wall Street. However, the mean target price is $275, 13% lower than its current share price.